These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32424937)

  • 21. RETRACTION: "Coinhibition of S1PR1 and GP130 by siRNA-loaded Alginate-conjugated Trimethyl Chitosan Nanoparticles Robustly Blocks Development of Cancer Cells".
    J Cell Physiol; 2024 Nov; 239(11):e31376. PubMed ID: 39034738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Mollarazi E; Kiani M; Razavi A; Yousefi M; Kheshtchin N; Hassannia H; Hadjati J; Shokri F
    Tumour Biol; 2016 Jun; 37(6):8403-12. PubMed ID: 26733167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy.
    Masjedi A; Ahmadi A; Ghani S; Malakotikhah F; Nabi Afjadi M; Irandoust M; Karoon Kiani F; Heydarzadeh Asl S; Atyabi F; Hassannia H; Hojjat-Farsangi M; Namdar A; Ghalamfarsa G; Jadidi-Niaragh F
    Nanomedicine; 2020 Oct; 29():102240. PubMed ID: 32553948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
    Kheshti AMS; Hajizadeh F; Barshidi A; Rashidi B; Ebrahimi F; Bahmanpour S; Karpisheh V; Noukabadi FK; Kiani FK; Hassannia H; Atyabi F; Kiaie SH; Kashanchi F; Navashenaq JG; Mohammadi H; Bagherifar R; Jafari R; Zolbanin NM; Jadidi-Niaragh F
    Pharm Res; 2022 Feb; 39(2):353-367. PubMed ID: 35166995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
    Karoon Kiani F; Izadi S; Ansari Dezfouli E; Ebrahimi F; Mohammadi M; Chalajour H; Mortazavi Bulus M; Nasr Esfahani M; Karpisheh V; Mahmoud Salehi Khesht A; Abbaszadeh-Goudarzi K; Soleimani A; Gholizadeh Navashenaq J; Ahmadi M; Hassannia H; Hojjat-Farsangi M; Shahmohammadi Farid S; Hashemi V; Jadidi-Niaragh F
    Life Sci; 2022 Jan; 288():120166. PubMed ID: 34813798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
    Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
    J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.
    Martin DT; Shen H; Steinbach-Rankins JM; Zhu X; Johnson KK; Syed J; Saltzman WM; Weiss RM
    Mol Cancer Ther; 2019 Feb; 18(2):413-420. PubMed ID: 30381445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
    Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

  • 31. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
    Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
    BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice.
    Ghalamfarsa G; Rastegari A; Atyabi F; Hassannia H; Hojjat-Farsangi M; Ghanbari A; Anvari E; Mohammadi J; Azizi G; Masjedi A; Yousefi M; Yousefi B; Hadjati J; Jadidi-Niaragh F
    J Cell Physiol; 2018 Oct; 233(10):7165-7177. PubMed ID: 29741783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling.
    Kim EY; Choi B; Kim JE; Park SO; Kim SM; Chang EJ
    Cells; 2020 Jan; 9(1):. PubMed ID: 31935914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells.
    Chen J; Dou Y; Tang Y; Zhang X
    Nanomedicine; 2020 Apr; 25():102173. PubMed ID: 32084593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.
    Xian S; Chen A; Wu Y; Wen H; Lu C; Huang F; Zeng Z
    Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34296288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
    Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
    Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway.
    Masjedi A; Hassannia H; Atyabi F; Rastegari A; Hojjat-Farsangi M; Namdar A; Soleimanpour H; Azizi G; Nikkhoo A; Ghalamfarsa G; Mirshafiey A; Jadidi-Niaragh F
    Int J Biol Macromol; 2019 Jul; 133():436-445. PubMed ID: 30936011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
    Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
    Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.